Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Highly Sensitive Laser Scanning to Advance Antibody Discovery

By LabMedica International staff writers
Posted on 31 Aug 2010
A new framework for highly sensitive laser scanning is now available to cell biologists and other life scientists working in the field of antibody discovery.

The new "Mirrorball” system is manufactured by TTP LabTech (Royston, United Kingdom), who maintain that it addresses one of the currently unmet needs of laser scanning instrumentation – that of high sensitivity. More...
In addition, Mirrorball is advertised as the first laser scanning microplate cytometer to offer simultaneous laser scanning.

Mirrorball operates at high sensitivity that enables detection of proteins that are only found at low abundance. This ensures that the instrument is perfectly suited to mix-and-read assays for hybridoma screening and cell-surface receptor expression. Simultaneous laser scanning results in superior multiplexing and analytical capabilities that enable robust and rapid data generation. Label-free detection takes place concurrently with fluorescence measurements resulting in improved object recognition and fewer false negatives, based on individual object count. Minimal autofluorescence due to proprietary low loss optics and red 640 nm laser excitation leads to a high signal-to-noise ratio and guarantees robust data generation.

Dr. Wayne Bowen, CSO at TTP LabTech, said, "Mirrorball is TTP LabTech's response to requests from scientists for novel technologies in antibody discovery. We have listened, developed, and now delivered a high sensitivity microplate cytometer for fluorescence cellular screening.”

Related Links:

TTP LabTech




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.